Plasma tranexamic acid concentrations during cardiopulmonary bypass

Anesthesia and Analgesia

Volumn 92, Issue 5, 2001, Pages 1131-1136

  Fiechtner, Bridget K ^a   Nuttall, Gregory A ^a,c   Johnson, Michael E ^a   Dong, Yue ^a   Sujirattanawimol, Nuntiya ^a   Oliver Jr , William C ^a   Sarpal, Rajbir S ^b   Oyen, Lance J ^a   Ereth, Mark H ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; FEMALE; FIBRINOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL;

EID: 0035033333     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200105000-00010     Document Type: Article

References (26)

1. Is ∈-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery? A meta-analysis
2. Economic impact of inappropriate blood transfusion in coronary artery bypass graft surgery
3. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA
4. Blood-sparing drugs: Aprotinin, tranexamic acid, and ∈-aminocaproic acid
5. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: Aprotinin vs tranexamic acid vs epsilon aminocaproic acid
6. A comparison of the effects of tranexamic acid and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing cardiac surgery
7. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass
8. The dose-response relationship of tranexamic acid
9. Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting
10. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization
11. Effect of tranexamic acid on platelet ADP during extracorporeal circulation
12. The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C)
13. Tranexamic acid reduces postbypass blood use: A double-blinded, prospective, randomized study of 210 patients
14. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: A double-blind, randomized, placebo-controlled trial
15. Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery
16. Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome
17. Measurement of free amino acids in human biological fluids by high-performance liquid chromatography
18. An ultra rapid and sensitive high-performance liquid chromatographic method for determination of tissue and plasma free amino acids
19. Quantitation of tryptophan and other plasma amino acids by automated precolumn o-phthalaldehyde derivatization sensitive high-performance liquid chromatography: Improved sample preparation
20. Properties of crystalline leucine dehydrogenase for Bacillus sphaericus
21. Spectrophotometric assay for measuring branched-chain amino acid concentrations: Application for measuring the sensitivity of protein metabolism to insulin
22. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass (CPB)
23. Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases
24. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers
25. Pharmacokinetics and bioavailability of tranexamic acid
26. Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man